EN
HI
Piramal Pharma Chart
Piramal Pharma Share Key Metrics
Volume
23.88 L
Market Cap
21287.91 CR
LTQ@LTP
1@161.68
ATP
158.7
Var Margin
18.13 %
Circuit Range
128.12-192.18
Delivery %
29.48 %
Value
37.90 CR
ASM/GSM
No
Market Lot
1
Summary
Piramal Pharma share price stands at ₹161.68 at 30 Apr, 2026 | 14:44. The stock Piramal Pharma intraday movement has stayed between ₹156.14 and ₹161.85, while on a 52-week basis it has fluctuated from ₹132.30 to ₹228.15.
In terms of trading activity, Piramal Pharma has recorded a volume of 2388066 shares. The Piramal Pharma has a market cap of ₹1329248130. The stock’s Average Traded Price (ATP) stands at ₹15870, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1, 16168.
The Piramal Pharma operates within a circuit range of ₹128.12-192.18 – ₹128.12-192.18, with a Value of ₹37.90 CR. The Delivery Percentage for the day is 29.48%. Additionally, Piramal Pharma currently falls under the No framework, and trades with a market lot size of 1.
Piramal Pharma Fundamentals
View MoreP/E Ratio
0
P/B Ratio
2.61
Div. Yield
0
Sector P/E
64.93
Sector P/B
3.52
Sec. Div. Yield
0.57
Piramal Pharma Resistance and Support
Pivot 162.73
Resistance
First Resistance
166.1
Second Resistance
172.04
Third Resistance
175.41
Support
First Support
156.79
Second Support
153.42
Third Support
147.48
Piramal Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-04-28 | Audited Results |
| 2026-01-28 | Quarterly Results |
| 2025-11-05 | Quarterly Results |
| 2025-07-28 | Quarterly Results |
| 2025-05-14 | Audited Results & Final Dividend |
| 2025-01-28 | Quarterly Results |
Piramal Pharma News
Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Piramal Pharma announced that the audio recording of its conference call held on April 29, 2026, regarding the Q4 FY26 audited financial results, is now available. Investors can access the recording on the company's website.
Apr 29 2026 16:04:00
Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Cessation
Piramal Pharma's Board re-appointed Ms. Nandini Piramal as Whole-Time Director, Executive Director, and Chairperson for a three-year term starting April 1, 2027, subject to shareholder approval.
Apr 28 2026 21:04:00
Read More
About Piramal Pharma
NSE : 11571
BSE : 543635
ISIN : INE0DK501011
Piramal Pharma Management
| Name | Position |
|---|---|
| Nandini Piramal | Chairperson |
| Peter DeYoung | Executive Director |
Piramal Pharma Similar Stocks
Krishna Institute of Medical Sciences Ltd
669.00
3.75 (0.56%)
Dr. Lal Pathlabs Ltd.
1375.30
-22.50 (1.61%)
Wockhardt Ltd.
1400.70
9.00 (0.65%)
Sai Life Sciences Ltd.
1074.70
19.60 (1.86%)
Pfizer Ltd.
4716.40
-46.60 (0.98%)
Acutaas Chemicals Ltd.
2565.60
63.20 (2.53%)
Onesource Specialty Pharma Ltd.
1703.90
-58.60 (3.32%)
Natco Pharma Ltd.
1099.35
5.75 (0.53%)
Cohance Lifesciences Ltd.
483.55
16.00 (3.42%)
Astrazeneca Pharma India Ltd.
8240.00
-129.00 (1.54%)
Piramal Pharma FAQs
The Buying Price of Piramal Pharma share is 161.68 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Piramal Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Piramal Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Piramal Pharma shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Piramal Pharma shares is 2.61. Useful to assess the stock's value relative to its book value.
To assess Piramal Pharma’s valuation compare Sector P/E, P/B which are 64.93 & 3.52 with sector averages, along with growth rates and financial metrics.
The Market Cap of Piramal Pharma is 21287.91 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Piramal Pharma share price is 228.15 & 132.30. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Piramal Pharma belongs to the Healthcare sector.
